» Authors » Raymond L Houghton

Raymond L Houghton

Explore the profile of Raymond L Houghton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 342
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Lodes M, Dillon D, Houghton R, Skeiky Y
Methods Mol Med . 2004 Feb; 94:91-106. PMID: 14959824
Expression cloning involves the selection of specific polypeptides, generated from a cDNA or genomic DNA library, based on certain characteristics of the expressed proteins, such as antibody or ligand binding,...
12.
Carter D, Dillon D, Reynolds L, Retter M, Fanger G, Molesh D, et al.
Clin Cancer Res . 2003 Feb; 9(2):749-54. PMID: 12576445
Lipophilin B mRNA is overexpressed in approximately 70% of breast tumors and shows a high degree of correlation with the mRNA expression profile of mammaglobin. This is further supported by...
13.
Homer M, Lodes M, Reynolds L, Zhang Y, Douglass J, McNeill P, et al.
J Clin Microbiol . 2003 Feb; 41(2):723-9. PMID: 12574273
The need for improved diagnostic reagents to identify human long-term carriers of the zoonotic parasite Babesia microti is evidenced by numerous reported cases of transfusion-acquired infections. This report describes the...
14.
Leiby D, Chung A, Cable R, Trouern-Trend J, McCullough J, Homer M, et al.
Transfusion . 2002 Dec; 42(12):1585-91. PMID: 12473139
Background: Tick-borne diseases, particularly babesiosis and ehrlichiosis, represent recently emerging infections. Despite an increased recognition of the threat tick-borne agents pose to blood safety, our understanding of the prevalence and...
15.
Houghton R, Homer M, Reynolds L, Sleath P, Lodes M, Berardi V, et al.
Transfusion . 2002 Nov; 42(11):1488-96. PMID: 12421223
Background: Babesia microti is a tick-borne agent that is increasingly implicated in transfusion-acquired infection, especially in immunocompromised and elderly recipients. To develop a test that can detect antibody responses to...
16.
Day C, Fanger G, Retter M, Hylander B, Penetrante R, Houghton R, et al.
Oncogene . 2002 Oct; 21(46):7114-20. PMID: 12370833
The ability to identify prostate tumor or prostate tissue specific genes that are expressed at high levels and use their protein products as targets could greatly aid in the diagnosis...
17.
Zehentner B, Dillon D, Jiang Y, Xu J, Bennington A, Molesh D, et al.
Clin Chem . 2002 Jul; 48(8):1225-31. PMID: 12142378
Background: Mammaglobin mRNA expression is found in 70-80% of primary and metastatic breast tumor biopsies. The potential breast tumor markers B305D, B726P, and gamma-aminobutyrate type A receptor pi subunit (GABApi)...
18.
Houghton R, Lodes M, Dillon D, Reynolds L, Day C, McNeill P, et al.
Clin Diagn Lab Immunol . 2002 Jul; 9(4):883-91. PMID: 12093690
Screening of genomic expression libraries from Mycobacterium tuberculosis with sera from tuberculosis (TB) patients or rabbit antiserum to M. tuberculosis led to the identification of novel antigens capable of detecting...
19.
Carter D, Douglass J, Cornellison C, Retter M, Johnson J, Bennington A, et al.
Biochemistry . 2002 May; 41(21):6714-22. PMID: 12022875
Mammaglobin, a promising diagnostic marker for breast cancer, forms a covalent complex with lipophilin B. mRNA levels for each component of the complex were determined for a number of breast...
20.
Jiang Y, Harlocker S, Molesh D, Dillon D, Stolk J, Houghton R, et al.
Oncogene . 2002 Apr; 21(14):2270-82. PMID: 11948410
Identifying novel and known genes that are differentially expressed in breast cancer has important implications in understanding the biology of breast tumorigenesis and developing new diagnostic and therapeutic agents. In...